Micro Genomics India Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-07-2024
- Paid Up Capital ₹ 1.46 Cr
as on 15-07-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.17 Cr
as on 15-07-2024
- Revenue 430.50%
(FY 2021)
- Profit 79.17%
(FY 2021)
- Ebitda 123.59%
(FY 2021)
- Net Worth -11.87%
(FY 2021)
- Total Assets -12.94%
(FY 2021)
About Micro Genomics India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.46 Cr.
The company currently has active open charges totaling ₹1.17 Cr.
Pradeepa Christina, Vaz Gnanam, and Gnaniah Rajaretnam serve as directors at the Company.
- CIN/LLPIN
U73100TN2016PTC112613
- Company No.
112613
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Micro Genomics India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaz Gnanam  | Director | 16-Aug-2017 | Current |
Pradeepa Christina  | Director | 12-Jun-2023 | Current |
| Gnaniah Rajaretnam | Director | 21-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Micro Genomics India.
Micro Genomics India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 430.5% increase. The company also saw a substantial improvement in profitability, with a 79.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Micro Genomics India?
In 2021, Micro Genomics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gscan Screening India Private LimitedActive 2 months 7 daysPradeepa Christina and Gnaniah Rajaretnam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Jan 2018 | ₹1.17 Cr | Open |
How Many Employees Work at Micro Genomics India?
Unlock and access historical data on people associated with Micro Genomics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Micro Genomics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Micro Genomics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
